Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease

Noguchi M, Sato T, Nagai K, Utagawa I, Suzuki I, Arito M, Iizuka N, Suematsu N, Okamoto K, Kato T, Yamaguchi N, Kurokawa MS.

Int J Geriatr Psychiatry. 2014 Aug;29(8):808-18. doi: 10.1002/gps.4047. Epub 2013 Nov 5.

Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze

Hort J, Andel R, Mokrisova I, Gazova I, Amlerova J, Valis M, Coulson EJ, Harrison J, Windisch M, Laczó J.

Neurodegener Dis. 2014;13(2-3):192-6. doi: 10.1159/000355517. Epub 2013 Oct 30.

Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult

Rosenblum WI.

Neurobiol Aging. 2014 May;35(5):969-74. doi: 10.1016/j.neurobiolaging.2013.10.085. Epub 2013 Oct 19.

The genesis of closing-in in Alzheimer disease and vascular dementia: a comparative clinical and experimental study

De Lucia N, Grossi D, Trojano L.

Neuropsychology. 2014 Mar;28(2):312-8. doi: 10.1037/neu0000036. Epub 2013 Nov 11.

Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets

Barone E, Di Domenico F, Butterfield DA.

Biochem Pharmacol. 2014 Apr 15;88(4):605-16. doi: 10.1016/j.bcp.2013.10.030. Epub 2013 Nov 11.

Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease

Kim SY, Choi SH, Rollema H, Schwam EM, McRae T, Dubrava S, Jacobsen J.

Dement Geriatr Cogn Disord. 2014;37(3-4):232-45. doi: 10.1159/000355373. Epub 2013 Nov 14.

Confidence interval estimation of the difference between two sensitivities to the early disease stage

Dong T, Kang L, Hutson A, Xiong C, Tian L.

Biom J. 2014 Mar;56(2):270-86. doi: 10.1002/bimj.201200012. Epub 2013 Nov 22.

Ultrahigh resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models

Lin S, Kanawati B, Liu L, Witting M, Li M, Huang J, Schmitt-Kopplin P, Cai Z.

Talanta. 2014 Jan;118:45-53. doi: 10.1016/j.talanta.2013.09.019. Epub 2013 Oct 5.

Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease

Gosselet F, Saint-Pol J, Fenart L.

Biochem Biophys Res Commun. 2014 Apr 11;446(3):687-91. doi: 10.1016/j.bbrc.2013.11.059. Epub 2013 Nov 22.

Acceptance of and attitudes towards Alzheimer's disease screening in elderly German adults

Braun SR, Reiner K, Tegeler C, Bucholtz N, Boustani MA, Steinhagen-Thiessen E.

Int Psychogeriatr. 2014 Mar;26(3):425-34. doi: 10.1017/S1041610213002044. Epub 2013 Nov 27.

Regenerative medicine in Alzheimer's disease

Felsenstein KM, Candelario KM, Steindler DA, Borchelt DR.

Transl Res. 2014 Apr;163(4):432-8. doi: 10.1016/j.trsl.2013.11.001. Epub 2013 Nov 8.

Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets

Falsafi SK, Roßner S, Ghafari M, Groessl M, Morawski M, Gerner C, Lubec G.

Amino Acids. 2014 Jan;46(1):223-33. doi: 10.1007/s00726-013-1623-9. Epub 2013 Nov 29.

Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells

Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ.

Mol Neurobiol. 2014 Aug;50(1):97-106. doi: 10.1007/s12035-013-8595-3. Epub 2013 Nov 29.

[Does gender really affect the socio-economic characteristics of the primary caregiver in Alzheimer's disease?]

Ruiz-Adame Reina M, González-Camacho MC, Mainar Causapé A.

Gac Sanit. 2014 May-Jun;28(3):258. doi: 10.1016/j.gaceta.2013.09.004. Epub 2013 Dec 2.

Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches

Mikulca JA, Nguyen V, Gajdosik DA, Teklu SG, Giunta EA, Lessa EA, Tran CH, Terak EC, Raffa RB.

J Clin Pharm Ther. 2014 Feb;39(1):25-37. doi: 10.1111/jcpt.12112. Epub 2013 Dec 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias